QI
USNA icon

QS Investors’s Usana Health Sciences USNA Stock Holding History

QS Investors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$840K Hold
8,200
– – 0.01% 539
2021
Q1 		$801K Buy
8,200
+2,130
+35% +$194K 0.01% 590
2020
Q4 		$468K Hold
6,070
– – 0.01% 814
2020
Q3 		$448K Sell
6,070
-20,280
-77% -$1.63M 0.01% 748
2020
Q2 		$1.94M Sell
26,350
-25
-0.1% -$1.96K 0.03% 504
2020
Q1 		$1.52M Hold
26,375
– – 0.02% 524
2019
Q4 		$2.06M Sell
26,375
-375
-1% -$27.6K 0.02% 578
2019
Q3 		$1.83M Sell
26,750
-1,400
-5% -$94K 0.02% 596
2019
Q2 		$2.24M Sell
28,150
-460
-2% -$36.5K 0.02% 552
2019
Q1 		$2.4M Buy
28,610
+27,605
+2,747% +$2.88M 0.03% 529
2018
Q4 		$119K Hold
1,005
– – ﹤0.01% 1282
2018
Q3 		$121K Sell
1,005
-800
-44% -$99.3K ﹤0.01% 1348
2018
Q2 		$208K Buy
1,805
+1,791
+12,793% +$196K ﹤0.01% 1201
2018
Q1 		$1K Hold
14
– – ﹤0.01% 1891
2017
Q4 		$1K Hold
14
– – ﹤0.01% 1899
2017
Q3 		$1K Hold
14
– – ﹤0.01% 1874
2017
Q2 		$1K Hold
14
– – ﹤0.01% 1888
2017
Q1 		$1K Hold
14
– – ﹤0.01% 1895
2016
Q4 		$1K Sell
14
-228
-94% -$14.9K ﹤0.01% 1777
2016
Q3 		$17K Hold
242
– – ﹤0.01% 1409
2016
Q2 		$13K Buy
242
+14
+6% +$844 ﹤0.01% 1439
2016
Q1 		$14K Sell
228
-4,600
-95% -$271K ﹤0.01% 1425
2015
Q4 		$308K Sell
4,828
-108,600
-96% -$7.04M ﹤0.01% 999
2015
Q3 		$7.6M Buy
113,428
+103,736
+1,070% +$7.34M 0.08% 233
2015
Q2 		$662K Sell
9,692
-68,748
-88% -$4.36M 0.01% 830
2015
Q1 		$4.36M Hold
78,440
– – 0.05% 416
2014
Q4 		$4.02M Buy
+78,440
New +$3.85M 0.05% 417
2014
Q2 		– Sell
-25,400
Closed -$957K – 816
2014
Q1 		$957K Buy
+25,400
New +$887K 0.03% 362
2013
Q4 		– Sell
-51,600
Closed -$2.24M – 631
2013
Q3 		$2.24M Sell
51,600
-29,400
-36% -$1.18M 0.1% 203
2013
Q2 		$2.93M Buy
+81,000
New +$2.46M 0.1% 240

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

QS Investors's USNA Position: Q2 2021 in Review

QS Investors held its Usana Health Sciences (USNA) position steady in Q2 2021 at 8,200 shares worth $840K. The position accounts for 0.01% of the portfolio, ranked #539.

QS Investors first reported a position in USNA in Q2 2013 and has held it in 30 quarters since. The position peaked at $7.6M in Q3 2015. 188 funds tracked by Wall St. Rank hold USNA as of Q2 2021.

  • QS Investors held 8,200 shares of Usana Health Sciences worth $840K as of Q2 2021.
  • QS Investors left its Usana Health Sciences share count unchanged in Q2 2021.
  • Usana Health Sciences made up 0.01% of QS Investors's portfolio in Q2 2021, its #539 holding.
  • QS Investors first reported a position in Usana Health Sciences in Q2 2013 and has held it in 30 quarters since.
  • QS Investors's Usana Health Sciences position peaked at $7.6M in Q3 2015.
  • 188 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.